PediaMed Pharmaceuticals Report issue

For profit Phase 2
Founded: Florence KY United States (1999)
Status: Acquired by Connetics (2006) → now GlaxoSmithKline (2009)

Organization Overview

First Clinical Trial
2005
NCT00110708
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

immune globulin (human) (Gamastan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Autistic Disorder (Phase 2)

Child Development Disorders, Pervasive (Phase 2)

Developmental Disabilities (Phase 2)

Digestive System Diseases (Phase 2)

Disease (Phase 2)

Gastrointestinal Diseases (Phase 2)

Signs and Symptoms (Phase 2)

Signs and Symptoms, Digestive (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1